resources

Media Coverage
March 29th, 2022

Poolbeg Pharma signs first of its kind AI deal with CytoReason

Media Coverage
February 10th, 2022

Pfizer re-ups CytoReason collab applying AI disease models to drug development

Media Coverage
April 16th, 2018

CytoReason uses AI to personalize drugs, opening the door to cancer treatments

Media Coverage
July 19th, 2018

Interview with Systems Immunology Expert Prof. Shai Shen-Orr

Media Coverage
July 17th, 2018

9 AI-based initiatives catalyzing immunotherapy in 2018

Media Coverage
November 25th, 2018

Five AI Healthcare Startups Bringing Us Closer to Cures

Bring your data to life